An observational study in Primary Dysmenorrhea, sponsored by Al Hayah University In Cairo. Recruiting at 1 site in Egypt. Open to female participants aged 18 Years to 23 Years. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by Al Hayah University In Cairo · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 37 studies in Dysmenorrhea with a site in Egypt — 13 open to participants now, 13 under way, none of them phase 3. Dysmenorrhea · Egypt.
Among the 37 studies in Dysmenorrhea with a site in Egypt, this one is the 6th largest by planned enrollment of the 12 observational ones that give a count, is one of 4 that started in 2026, is one of 12 observational ones, reaches primary completion later than 11 of the 12 other live ones, and was the 37th registered.
432 studies on the registry are indexed under Dysmenorrhea; 108 are open to participants now.
Browse Dysmenorrhea studies →13 of the 37 studies in Dysmenorrhea with a site in Egypt are open now. Recruiting first, the newest first:
Kafrelsheikh University · Sites in Egypt
Ages 20–25 · Women only
Cairo University · Sites in Egypt
Ages 18–25 · Women only · Healthy volunteers
Cairo University · Sites in Egypt
Ages 18–25 · Women only
New Ismailia National University · Sites in Egypt, Jordan
Ages 13–20 · Women only · Healthy volunteers
Delta University for Science and Technology · Sites in Egypt
Ages 18–35 · Women only
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 58 Dysmenorrhea studies recruiting now, 7 (12%) set no upper age limit and 50 (86%) stop at 75 or younger; 11 take children under 18; 20 take healthy volunteers.
This study: 18 Years to 23 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
37 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 79 is below the median of 100 across 59 observational studies indexed under Dysmenorrhea.
Median enrollment 58 across the 25 interventional studies, 78 across the 12 observational. Of the 23 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 37 has an industry lead sponsor. The 10 most frequent:
Al Hayah University In Cairo is the lead sponsor of 16 studies on the registry; 14 are open to participants now.
Al Hayah University In Cairo has 1 study filed under Dysmenorrhea — fewer than ten, so there is no comparison to draw.
1 of the studies in Dysmenorrhea with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07935668Al Hayah University In CairoAssociation Between Menstrual Pain Severity and Plantar Pressure in Young Women | 2027-02-01 |
Add it to your calendar (.ics) → With an account.
Among the 37 studies in Dysmenorrhea with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Primary dysmenorrhea is a common condition characterized by recurrent menstrual pain in the absence of identifiable pelvic pathology. Menstrual pain may be accompanied by changes in posture, neuromuscular function, and postural control. These changes may influence how body weight is distributed across the feet during standing.
The purpose of this observational study is to investigate the association between primary dysmenorrhea severity and plantar pressure distribution in post-pubertal females.
The study will include 79 female university students aged 18-23 years with a history of primary dysmenorrhea. Participants will be recruited from the first through fourth academic years of the Faculty of Physical Therapy at Al Hayat University in Cairo, Egypt.
Each participant will undergo a single assessment during the menstrual phase, specifically within the first three days of menstruation.
Primary dysmenorrhea severity will be assessed using the Working Ability, Location, Intensity, Days of Pain, Dysmenorrhea (WaLIDD) scale. The scale produces a total score ranging from 0 to 12, with higher scores indicating greater severity.
Plantar pressure distribution will be assessed using the DIERS pedoscan system during standardized barefoot quiet standing. The assessment will include plantar pressure distribution and anterior-posterior and right-left weight distribution.
A minimum of two valid 30-second standing measurements will be obtained and averaged for analysis.
The study will examine whether greater primary dysmenorrhea severity is associated with measurable differences in plantar pressure distribution and weight-bearing characteristics.
No therapeutic intervention, randomization, or experimental treatment allocation will be performed.
The study population consists of female undergraduate physical therapy students aged 18-23 years attending the first through fourth academic years at Al Hayat University in Cairo, Egypt. Eligible participants will have primary dysmenorrhea, regular menstrual cycles, and the ability to complete a standardized standing plantar pressure assessment. A total of 79 participants is planned. Each participant will be assessed during menstrual Days 1-3.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A single group of 79 post-pubertal females aged 18-23 years with primary dysmenorrhea will be recruited from undergraduate physical therapy students at Al Hayat University in Cairo. Participants will have regular menstrual cycles, a history of primary dysmenorrhea for at least six consecutive months, and the ability to stand independently for pedobarographic assessment. Dysmenorrhea severity and plantar pressure parameters will be assessed at a single visit during menstrual Days 1-3.
Other: primary Dysmenorrhea Severity
The exposure of interest is the severity of primary dysmenorrhea, quantified using the self-reported WaLIDD scale. The instrument evaluates working ability, pain location, pain intensity, and duration of pain. Each domain contributes 0-3 points to a total score ranging from 0 to 12. Higher scores indicate greater severity. Dysmenorrhea severity will be examined for its association with objectively measured plantar pressure distribution and weight-bearing characteristics during standing. This is an observed characteristic and not an investigator-assigned intervention.
Static Plantar Pressure Distribution
Plantar pressure distribution will be assessed using the DIERS pedoscan computerized pedobarographic platform during standardized barefoot quiet standing. Participants will stand with feet shoulder-width apart, arms relaxed at their sides, and eyes directed forward. At least two valid 30-second recordings will be obtained and averaged. The recorded plantar loading distribution will be analyzed in relation to primary dysmenorrhea severity. The precise regional pressure outputs and measurement units must be defined from the study's DIERS reporting protocol before submission.
Time frame: Single assessment during menstrual Days 1-3; at least two 30-second standing recordings.
Primary Dysmenorrhea Severity Assessed by WaLIDD Score
Primary dysmenorrhea severity will be quantified using the Working Ability, Location, Intensity, Days of Pain, Dysmenorrhea (WaLIDD) scale. The instrument contains four domains, each scored from 0 to 3, resulting in a total score ranging from 0 to 12. Higher scores represent greater symptom severity. Scores are categorized as absent (0), mild (1-4), moderate (5-7), or severe (8-12). The total score will be used as the principal severity variable in the correlational analysis.
Time frame: Single assessment during menstrual Days 1-3.
Anterior-Posterior Weight Distribution (%)
Anterior-posterior weight distribution will be measured using the DIERS pedoscan system during standardized barefoot quiet standing. The instrument will quantify the distribution of body weight between the anterior and posterior plantar regions, expressed as percentages. At least two valid 30-second recordings will be obtained and averaged for analysis.
Time frame: Single assessment during menstrual Days 1-3; at least two 30-second standing recordings.
Right-Left Weight Distribution (%)
Right-left weight distribution will be assessed using the DIERS pedoscan computerized pressure platform. The measurement will quantify the percentage of body weight distributed between the right and left lower limbs during standardized barefoot quiet standing. At least two valid 30-second recordings will be obtained and averaged for analysis.
Time frame: Single assessment during menstrual Days 1-3; at least two 30-second standing recordings.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Feb 2027, 2 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Al Hayah University In Cairo